Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
02:37:52 EST Sat 07 Feb 2026
Enter Symbol
or Name
USA
CA



Q:CPRX - CATALYST PHARMACEUTICALS INC - https://www.copper-ridge.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
CPRX - Q0.124.00·25.250.424.44+0.532.21,031.124,5539,75724.27  24.58  23.7326.58  19.0519:25:24Jan 0815 min RT 2¢

Recent Trades - Last 10 of 9757
Time ETExPriceChangeVolume
19:25:24Q25.251.3445
19:10:05Q25.301.397
18:59:12Q24.350.441
18:59:12Q24.350.443
18:23:45Q25.301.3925
18:13:06Q24.340.434
17:05:52Q25.301.392
16:42:05Q25.301.393
16:37:04Q24.340.432
16:33:37Q24.340.431

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-08 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Receives Prestigious Ranking on Forbes 2026 List of America's Most Successful Small-Cap Companies
2026-01-05 08:03U:CPRXNews ReleaseThe University of Notre Dame and Catalyst Pharmaceuticals Host Inaugural Catalyst Advocacy Scholars Summit (CASS)
2025-12-15 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-11-24 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in the Bank of America CNS Therapeutics Virtual Conference
2025-11-19 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Recognized as One of North America's Fastest-Growing Companies on the 2025 Deloitte Technology Fast 500(TM)
2025-11-18 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in Citi's 2025 Global Healthcare Conference
2025-11-05 16:07U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Business Update
2025-11-04 16:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Recognized Among BioSpace 2026 Best Places to Work
2025-11-03 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in Jefferies Global Healthcare Conference
2025-10-22 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 5, 2025
2025-10-09 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Announces Presentations at Upcoming Scientific Conferences
2025-10-01 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Announces $200 Million Share Repurchase Program
2025-08-28 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Participate in Upcoming Investor Conferences
2025-08-26 19:13U:CPRXNews ReleaseUPDATED- Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE(TM) (amifampridine) Patent Litigation with Lupin Pharmaceuticals
2025-08-25 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Announces Settlement of FIRDAPSE(TM) (amifampridine) Patent Litigation with Lupin Pharmaceuticals
2025-08-06 16:13U:CPRXNews ReleaseCatalyst Pharmaceuticals Reports Record Second Quarter and First Half 2025 Financial Results; Provides Business Update
2025-08-06 08:03U:CPRXNews ReleaseLambert Eaton Myasthenic Syndrome (LEMS) Antibody Testing and Treatment Recommendations Added to NCCN Clinical Practice Guidelines for Small Cell Lung Cancer (SCLC)
2025-08-04 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Appoints Daniel Curran, MD, to its Board of Directors
2025-07-22 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
2025-06-02 08:03U:CPRXNews ReleaseCatalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer